Cargando…
Evolution and Prospects for Intracranial Pharmacotherapy for Refractory Epilepsies: The Subdural Hybrid Neuroprosthesis
Intracranial pharmacotherapy is a novel strategy to treat drug refractory, localization-related epilepsies not amenable to resective surgery. The common feature of the method is the use of some type of antiepileptic drug (AED) delivery device placed inside the cranium to prevent or stop focal seizur...
Autores principales: | Ludvig, Nandor, Medveczky, Geza, French, Jacqueline A., Carlson, Chad, Devinsky, Orrin, Kuzniecky, Ruben I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428620/ https://www.ncbi.nlm.nih.gov/pubmed/22937227 http://dx.doi.org/10.1155/2010/725696 |
Ejemplares similares
-
Functional neuroimaging abnormalities in idiopathic generalized epilepsy
por: McGill, Megan L., et al.
Publicado: (2014) -
A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
por: Romanelli, Pantaleo, et al.
Publicado: (2019) -
Detection of Epileptogenic Cortical Malformations with Surface-Based MRI Morphometry
por: Thesen, Thomas, et al.
Publicado: (2011) -
Effect of Joint Friction Compensation on a “Muscle-First” Motor-Assisted Hybrid Neuroprosthesis
por: Reyes, Ryan-David, et al.
Publicado: (2020) -
Perceptual confidence neglects decision-incongruent evidence in the brain
por: Peters, Megan A. K., et al.
Publicado: (2017)